高血压患者高血清A-FABP水平可作为代谢综合征患者主动脉僵硬度潜在生物标志物
该研究纳入110例高血压患者,检测空腹血清A-FABP浓度并评估动脉僵硬度和代谢综合征。结果显示血清A-FABP与MetS和高动脉僵硬度正相关,在合并MetS的高血压患者中log-A-FABP与动脉僵硬度显著正相关,提示A-FABP可作为预测指标。
要点
- 高血压患者中血清A-FABP与代谢综合征及高动脉僵硬度正相关
- 合并MetS的高血压患者中log-A-FABP与动脉僵硬度独立正相关
- A-FABP可能作为高血压患者代谢综合征和动脉僵硬的预测生物标志物
核心结论
- 升高的A-FABP浓度可能是高血压患者代谢综合征和动脉僵硬的预测指标。
研究设计与样本
- 研究纳入110例高血压患者,获取空腹血样和基线特征,用酶免疫检测试剂盒测定血清A-FABP浓度,通过SphygmoCor系统测量颈股脉搏波速度以定义高动脉僵硬度(>10m/s)。
主要发现
- 代谢综合征和高动脉僵硬度的患者分别占研究人群的67.3%和42.7%。
- 血清A-FABP与代谢综合征正相关(P=0.006),与高动脉僵硬度正相关(P<0.001)。
- 多变量逐步线性回归显示对数转换的A-FABP(log-A-FABP,β=0.278,P=0.002)与高血压患者动脉僵硬度正相关。
临床怎么用
- 在高血压患者中可考虑检测血清A-FABP水平,辅助识别代谢综合征和动脉僵硬高风险个体。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The adipocyte-fatty-acid-binding protein (A-FABP) has been implicated in arterial stiffness, metabolic syndrome (MetS), and cardiovascular disease. We aimed to determine the relationship among serum A-FABP concentration, cardiometabolic risk factors, and central arterial stiffness in a hypertensive population. METHODS: Fasting blood samples and baseline characteristics were obtained from 110 hypertensive patients. Serum A-FABP concentrations were determined by enzyme immunoassay kit. High arterial stiffness was defined as carotid-femoral pulse wave velocity values >10m/s via the SphygmoCor system. RESULTS: Patients with MetS and high arterial stiffness accounted for 67.3% and 42.7% of the study population, respectively. Serum A-FABP was positively associated with MetS and high arterial stiffness (P=0.006 and P<0.001, respectively). Multivariable stepwise linear regression analysis of the significant variables of arterial stiffness revealed that logarithmically transformed A-FABP (log-A-FABP, β=0.278, P=0.002) was positively correlated arterial stiffness in hypertensive patients. Subgroup analysis revealed that log-A-FABP (β=0.327, P=0.003), age (β=0229, P=0.032), and triglyceride (β=0.307, P=0.004) were significantly positively correlated with arterial stiffness in hypertensive patients with MetS. CONCLUSIONS: Elevated A-FABP concentration could be a predictor for MetS and arterial stiffness in hypertensive patients.
引用
- Chen MC, Hsu BG, Lee CJ, et al. High serum adipocyte fatty acid binding protein level as a potential biomarker of aortic arterial stiffness in hypertensive patients with metabolic syndrome. Clin Chim Acta. 2017. PMID: 28860092. doi:10.1016/j.cca.2017.08.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。